FT News Briefing30 Jul 2022

FT Weekend: A new weight-loss drug works. Is that good?

This week, we hear about a new 'miracle' weight-loss drug called Wegovy. It has unprecedented clinical results and endorsements from celebrities such as Queen Latifah. But critics say it deals with the symptom but not the cause. Then, we’re joined by Lauren Indvik, the FT's fashion editor. She explains how to efficiently pinpoint your personal style, and build a wardrobe that saves money, time and carbon emissions. Plus, she answers listener questions.

--------------

Want to stay in touch? We love hearing from you. We’re on Twitter @ftweekendpod, and Lilah is on Instagram and Twitter @lilahrap.

--------------

Links and mentions from the episode:

– Hannah Kuchler’s piece, ‘A new ‘miracle’ weight loss drug really works – raising huge questions’: https://on.ft.com/3vpSBQh

– Lauren Indvik’s dispatch from the Paris runway, ‘A return to decadence at Paris couture’: https://on.ft.com/3BoXNrl

– Hannah Kuchler is on Twitter @hannahkuchler. Lauren is on Twitter @laureni.

—-----------

Special offers for FT Weekend listeners, from 50% off a digital subscription to a $1/£1/€1 trial can be found here: http://ft.com/weekendpodcast

Want to join us at the FT Weekend festival in London on September 3rd? Buy a ticket at ft.com/ftwf. And here’s a special £20 off promo code, specifically for FT Weekend listeners: FTWFxPodcast22

--------------

Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2191)

SpaceX outperforms in debut earnings

SpaceX surpassed analysts’ expectations in its debut earnings report, China is hunting for hundreds of billions of dollars in unpaid taxes and power cuts in Tunisia have provoked protests against Pres...

5 Aug 12min

America’s puzzling yen intervention

Novo Nordisk’s CEO checks in on his first year at the helm, and Russia is quietly assembling a "shadow fleet" of ships to circumvent EU sanctions. Plus, we take a deep dive into a historic joint inter...

4 Aug 12min

Spain’s migrant crisis reopens deep EU rifts

UK drugmaker AstraZeneca is in talks to combine with US rival Bristol Myers Squibb, and European governments will hold an online meeting to discuss Spain’s migrant crisis. Plus, wildfires and heatwave...

3 Aug 11min

JPMorgan walks into another football firestorm

Amazon reported accelerated cloud growth in the quarter to the end of June, and JPMorgan has walked into another football firestorm as it works on a plan with Fifa. Plus, Citadel bought Situational Aw...

31 Jul 13min

Fed holds rates as inflation fears grow

Meta and Microsoft reported quarterly earnings as investors raised concerns about AI spending, and the US Federal Reserve held interest rates steady. The Bank of Japan is also expected to leave rates ...

30 Jul 12min

The Big Tech earnings dilemma

Ukraine is shifting its long-range drone campaign to focus on critical Russian infrastructure, and Big Tech companies are facing an AI dilemma as they report quarterly earnings. Plus, Google DeepMind ...

29 Jul 12min

Ares’ big play in private equity

A crucial gauge of risk in holding the debt of companies at the centre of the AI boom has hit a record high, private capital group Ares Management has held talks to acquire Leonard Green & Partners, a...

28 Jul 12min

Hike or hold: Investors split ahead of Fed decision

Investors raised their bets the Federal Reserve will raise rates on Wednesday after this month’s jump in oil prices. And, firefighting efforts were boosted in France and Spain as “violent” wildfires r...

27 Jul 11min